Ensign Peak Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.3M Buy
64,731
+6,992
+12% +$1.86M 0.05% 251
2026
Q1
$6.33M Sell
57,739
-21,754
-27% -$3.1M 0.01% 490
2025
Q4
$13.2M Sell
79,493
-55,051
-41% -$9.21M 0.02% 353
2025
Q3
$26.3M Buy
134,544
+102,079
+314% +$16.8M 0.04% 274
2025
Q2
$2.94M Buy
+32,465
New +$2.56M 0.01% 783
2025
Q1
Sell
-8,950
Closed -$1.19M 1732
2024
Q4
$1.19M Buy
+8,950
New +$840K ﹤0.01% 1215

Other funds holding ALAB

Ensign Peak Advisors's ALAB Position: Q2 2026 in Review

Ensign Peak Advisors increased its Astera Labs (ALAB) stake by 12% in Q2 2026, buying an estimated $1.86M and bringing the position to 64,731 shares worth $31.3M. The position accounts for 0.05% of the portfolio, ranked #251.

Ensign Peak Advisors first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Ensign Peak Advisors held 64,731 shares of Astera Labs worth $31.3M as of Q2 2026.
  • Ensign Peak Advisors bought 6,992 Astera Labs shares in Q2 2026, an estimated $1.86M.
  • Astera Labs made up 0.05% of Ensign Peak Advisors's portfolio in Q2 2026, its #251 holding.
  • Ensign Peak Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.